Recurrent pregnancy loss and future risk of female malignancies
- 66 Downloads
To investigate whether patients with a history of recurrent pregnancy loss (RPL) have an increased risk for future female malignancies.
A retrospective population-based study compared the incidence of long-term female malignancies in a cohort of women with and without a history of RPL (2 or more consecutive pregnancy losses). Deliveries occurred between the years 1988 and 2013, with a mean follow-up duration of 12 years. Women with known malignancies before the index pregnancy were excluded from the analysis. Female malignancies were divided according to specific type including ovary, breast, uterine and uterine cervix. Kaplan–Meier survival curve was used to estimate the cumulative incidence of malignancies. Cox proportional hazards model was used to determine the adjusted hazard ratios (HR) for female malignancy after controlling for confounders.
During the study period, 106,265 patients met the inclusion criteria; 6.6% (n = 7052) of patients had a diagnosis of RPL. During the follow-up period, patients with RPL had a significantly increased risk of being diagnosed with female malignancies as a group, while individually there was an increased risk of breast and uterine cervix cancer. Using a Kaplan–Meier survival curve, patients with a history of RPL had a significantly higher cumulative incidence of female malignancies. Using a Cox proportional hazards model, adjusted for confounders such as smoking, parity, and diabetes mellitus, a history of RPL remained independently associated with female malignancies (adjusted HR 1.4; P = 0.003).
RPL is independently associated with long-term female malignancies. Patients with a history of RPL may benefit from counseling and screening for breast and uterine cervix cancer in particular.
KeywordsRecurrent pregnancy loss Long-term risk Ovarian cancer Uterine cancer Breast cancer Cervical cancer
RC manuscript writing, protocol development, project administration. ES protocol development, manuscript editing. OB manuscript editing, project administration. RS data analysis. RK protocol development, manuscript editing.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval with regard to research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
No humans involved in this article.
- 1.Fraser A, Nelson SM, Macdonald-Wallis C, Cherry L, Butler E, Sattar N et al (2012) Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation 125(11):1367–1380CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Lukanova A, Kaaks R (2005) Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomark Prev 14(1):98–107Google Scholar
- 14.Desantis C, Ma J, Bryan L, Jemal A (2013) Breast cancer statistics, 2013. CA Cancer J Clin 34:52–62Google Scholar
- 15.Permuth-Wey J, Besharat A, Sellers TA (2014) Epidemiology of ovarian cancer: an update. In: Farghaly SA (ed) Advances in diagnosis and management of ovarian cancer. Springer, Boston, MA, PA, pp 1–21Google Scholar
- 24.American College of Obstetricians and Gynecologists (2002) ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 78(2):179–190CrossRefGoogle Scholar
- 30.Beral V, Bull D, Doll R, Peto R, Reeves G, Collaborative Group on Hormonal Factors in Breast Cancer (2004) Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83,000 women with breast cancer from 16 countries. Lancet 363(9414):1007–1016CrossRefPubMedGoogle Scholar
- 32.Dick ML, Siskind V, Purdie DM, Green AC (2009) Australian Cancer Study Group (Ovarian Cancer), Australian Ovarian Cancer Study Group. Incomplete pregnancy and risk of ovarian cancer: results from two Australian case–control studies and systematic review. Cancer Causes Control 20(9):1571–1585CrossRefPubMedGoogle Scholar
- 40.Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (1975–2015) SEER Cancer Statistics Review, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/ based on November 2017 SEER data submission, posted to the SEER web site, April 2018